Cart
sales@molnova.com
MARK Substrate
CAS No. 847991-34-8
MARK Substrate( —— )
Catalog No. M30539 CAS No. 847991-34-8
MARK Substrate is a MARK substrate peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 138 | Get Quote |
|
| 10MG | 214 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMARK Substrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMARK Substrate is a MARK substrate peptide.
-
DescriptionMARK Substrate is a MARK substrate peptide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847991-34-8
-
Formula Weight1417.61
-
Molecular FormulaC60H108N18O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (70.54 mM)
-
SMILES——
-
Chemical NameSequence:Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Otophylloside P
Otophylloside P
-
Dehydrocurdione
Dehydrocurdione, a zedoary-derived sesquiterpene, induces heme oxygenase (HO)-1, an antioxidative enzyme, in RAW 264.7 macrophages. Dehydrocurdione interacts with Keap1, resulting in Nrf2 translocation followed by activation of the HO-1 E2 enhancer. Dehydrocurdione suppresses lipopolysaccharide-induced NO release, a marker of inflammation. Anti-inflammatory activity.
-
Teprotumumab
Teprotumumab is a human monoclonal antibody that blocks the IGF-1 receptor (IGF-1R). Teprotumumab binds to the extracellular α-subunit domain ligand of IGF-1R.
